Scleroderma symptoms may be localized, primarily affecting the skin and underlying tissues. It may also be systemic, affecting your skin as well as the blood vessels and tissues of major organ ...

Explore new findings on frailty in systemic sclerosis, revealing its prevalence, dynamic progression, and impact on patient ...

Sex-related differences in pulmonary complications were found among men vs women with SSc, specifically in the prevalence of ILD and SAD.

Anifrolumab is under clinical development by AstraZeneca and currently in Phase III for Systemic Sclerosis (Scleroderma). According to GlobalData, Phase III drugs for Systemic Sclerosis (Scleroderma) ...

The following is a description of manifestations of systemic scleroderma (SSc ... [2] Patients with diffuse cutaneous scleroderma with skin thickening on the proximal extremities or the trunk ...

Century Therapeutics (IPSC) has entered into an agreement for an investigator-initiated Phase 1/2 trial by Professors Georg Schett and Andreas ...

PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) has cemented a collaboration with renowned cell therapy leaders Professors Georg Schett and Andreas Mackensen to initiate a Phase 1/2 trial ...

PHILADELPHIA - Century Therapeutics, Inc. (NASDAQ: IPSC), a biotechnology firm with a market capitalization of $77.32 million ...

T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...

Relapsing-remitting multiple sclerosis is a type of multiple sclerosis in which you experience relapses of the disease with periods of remission occurring in between. Relapsing-remitting multiple ...

Jan. 21, 2025 — Researchers identified a key protein as a potential therapeutic target for stopping the body's immune system from mistakenly attacking itself, offering new hope for treating ...

Pytorch 1.9.0, Python 3.9 $ conda create --name DiffuseIT python=3.9 $ conda activate DiffuseIT $ pip install ftfy regex matplotlib lpips kornia opencv-python torch ...